Acadian Asset Management’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$369K Sell
20,421
-2,606
-11% -$47.1K ﹤0.01% 1200
2025
Q1
$219K Buy
23,027
+6,823
+42% +$64.9K ﹤0.01% 1242
2024
Q4
$255K Buy
16,204
+2,646
+20% +$41.6K ﹤0.01% 1215
2024
Q3
$203K Hold
13,558
﹤0.01% 1353
2024
Q2
$184K Buy
13,558
+7,690
+131% +$104K ﹤0.01% 1441
2024
Q1
$78K Hold
5,868
﹤0.01% 1322
2023
Q4
$57K Sell
5,868
-1,088
-16% -$10.6K ﹤0.01% 1444
2023
Q3
$73K Sell
6,956
-2,532
-27% -$26.6K ﹤0.01% 1362
2023
Q2
$130K Sell
9,488
-3,641
-28% -$49.9K ﹤0.01% 1354
2023
Q1
$132K Sell
13,129
-8,296
-39% -$83.4K ﹤0.01% 1339
2022
Q4
$332K Sell
21,425
-2,721
-11% -$42.2K ﹤0.01% 1148
2022
Q3
$474K Sell
24,146
-22,500
-48% -$442K ﹤0.01% 1002
2022
Q2
$1.18M Sell
46,646
-30,638
-40% -$772K 0.01% 780
2022
Q1
$1.91M Sell
77,284
-56,779
-42% -$1.4M 0.01% 679
2021
Q4
$3.75M Buy
134,063
+16,336
+14% +$456K 0.01% 524
2021
Q3
$4.91M Sell
117,727
-12,844
-10% -$536K 0.02% 450
2021
Q2
$6.08M Buy
130,571
+41,527
+47% +$1.93M 0.02% 422
2021
Q1
$4.92M Buy
89,044
+31,809
+56% +$1.76M 0.02% 484
2020
Q4
$4.15M Buy
57,235
+54,232
+1,806% +$3.94M 0.02% 549
2020
Q3
$593K Buy
+3,003
New +$593K ﹤0.01% 1079
2018
Q4
Sell
-80
Closed -$36K 1714
2018
Q3
$36K Hold
80
﹤0.01% 1428
2018
Q2
$38K Buy
80
+26
+48% +$12.4K ﹤0.01% 1446
2018
Q1
$32K Sell
54
-62
-53% -$36.7K ﹤0.01% 1431
2017
Q4
$63K Sell
116
-2,186
-95% -$1.19M ﹤0.01% 1190
2017
Q3
$965K Buy
2,302
+941
+69% +$394K ﹤0.01% 689
2017
Q2
$338K Buy
1,361
+501
+58% +$124K ﹤0.01% 886
2017
Q1
$263K Buy
860
+506
+143% +$155K ﹤0.01% 1000
2016
Q4
$52K Buy
+354
New +$52K ﹤0.01% 1176